Company: MDCXW
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001062993-25-015841
Chunk: 268

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-29
Form: S-1
Chunk 268
---
 of Subsidiaries of Medicus Pharma Ltd.                                                                                                                                                                                                                                       |
| 23.1^   | Consent of EisnerAmper LLP                                                                                                                                                                                                                                                        |
| 23.2^   | Consent of MNP LLP                                                                                                                                                                                                                                                                |
| 23.3^   | Consent of Bennett Jones LLP (included in Exhibit 5.1)                                                                                                                                                                                                                            |
| 24.1^   | Powers of Attorney (included in the signature page to this Registration Statement)                                                                                                                                                                                                |
| 107^    | Filing fee table                                                                                                                                                                                                                                                                  |

_____________________

^Filed herewith.

+Indicates a management contract or compensatory plan.

*Certain portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The Company hereby undertakes to furnish supplementally copies of any of the omitted schedules upon request by the SEC.

#Schedules and certain other private or confidential information (as indicated therein) have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company hereby undertakes to furnish supplementally copies of any of the omitted schedules upon request by the SEC.

† Certain private or confidential information (as indicated therein) have been redacted pursuant to Item 601(a)(6) of Regulation S-K.

<div align='center'>II-8

SIGNATURES</div>

Pursuant to the requirements of the Securities Act, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in W. Conshohocken, Pennsylvania this 29 day of September, 2025.

| MEDICUS PHARMA LTD. |                                                       |
| By:                 | /s/ Raza Bokhari                                      |
|                     | Name: Dr. Raza Bokhari                                
 Title: Executive Chairman and Chief Executive Officer |

<div align='center'>POWERS OF ATTORNEY</div>

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Dr. Raza Bokhari,Carolyn Bonner, Maryann Adessoor James Quinlan, or any of them, with full power to act alone, his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any or all amendments or supplements to this registration statement, whether pre-effective or